Gail K. Naughton: Difference between revisions
WikiModEn2 (talk | contribs) Add SEEALSO section. |
WikiModEn2 (talk | contribs) Add LINKS section. |
||
| Line 1: | Line 1: | ||
'''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland. | '''Gail K. Naughton''', Pd.D., was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland. | ||
Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb | Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb | ||
| Line 12: | Line 12: | ||
{{SEEALSO}} | {{SEEALSO}} | ||
* [[United States of America]] | * [[United States of America]] | ||
{{LINKS}} | |||
* {{REFweb | |||
|url=https://www.lji.org/team-member/gail-naughton-ph-d-mba/ | |||
|title=Gail K. Naughton, Ph.D., MBA | |||
|last= | |||
|first= | |||
|init= | |||
|publisher=La Jolla Institute for Imunology | |||
|date= | |||
|accessdate=2024-05-02 | |||
}} | |||
{{REF}} | {{REF}} | ||